Spectranetics (SPNC) Tops Q2 EPS by 18c; Lowers FY15 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Spectranetics Reports Second Quarter Financial Results
July 23, 2015 4:01 PM EDTCOLORADO SPRINGS, Colo., July 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ: SPNC) today reported financial results for the three and six months ended June 30, 2015. Highlights of the quarter, all compared with the three months ended June 30, 2014 include:
Revenue of $61.7 million increased 42% (45% constant currency1); 9% (12% constant currency) excluding AngioSculpt® Vascular Intervention revenue of $26.4 million, excluding AngioSculpt, increased 17% (19% constant currency) U.S. peripheral atherectomy revenue grew 21% AngioSculpt revenue of $14.2 million Lead Management revenue of $17.3 million increased 7% (11% constant currency) Laser, service and other revenue of $3.8 million decreased 23% (21%... More